Verigene II
Device
Luminex Corporation
Total Payments
$710,703
Transactions
7
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $710,703 | 7 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $710,703 | 7 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| ATL-RTI-01 Verigene II RSP/RSP Expanded | Luminex Corporation | $633,588 | 0 |
| ATL-CNS-01 VERIGENE II CNS Flex Panel | Luminex Corporation | $50,116 | 0 |
| ATL-EPF-01Verigene II GI/GI-2 | Luminex Corporation | $21,169 | 0 |
| ATL-CSN-01 Verigine II CNS Flex Assay | Luminex Corporation | $3,294 | 0 |
| ATL-EPF-01 Verigene II GI/GI-2 | Luminex Corporation | $1,860 | 0 |
| VER-BCY-01 VERIGENE II BC Yeast Assay | Luminex Corporation | $675.00 | 0 |
Top Doctors Receiving Payments for Verigene II
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Los Angeles, CA | $710,703 | 7 |
Ad
Manufacturing Companies
- Luminex Corporation $710,703
Product Information
- Type Device
- Total Payments $710,703
- Total Doctors 0
- Transactions 7
About Verigene II
Verigene II is a device associated with $710,703 in payments to 0 healthcare providers, recorded across 7 transactions in the CMS Open Payments database. The primary manufacturer is Luminex Corporation.
Payment data is available from 2023 to 2023. In 2023, $710,703 was paid across 7 transactions to 0 doctors.
The most common payment nature for Verigene II is "Unspecified" ($710,703, 100.0% of total).
Verigene II is associated with 6 research studies, including "ATL-RTI-01 Verigene II RSP/RSP Expanded" ($633,588).